JOHN EBLE, M.D.
Medical Practice at Barnhill Dr, Indianapolis, IN
License number
Indiana 01027516A
Category
Medical Practice
Type
Clinical Pathology/Laboratory Medicine
Address
Address
635 Barnhill Dr, Indianapolis, IN 46202
Phone
(317) 274-4806
Personal information
See more information about JOHN EBLE at radaris.comName
Address
Phone
7601 Newport Bay Dr APT 303, Indianapolis, IN 46240
5850 Winding Way Ln, Indianapolis, IN 46220
3750 Haverhill Dr, Fishers, IN 46038
3750 Haverhill Dr, Indianapolis, IN 46240
4323 Broadway St, Indianapolis, IN 46205
Organization information
See more information about JOHN EBLE at bizstanding.comJohn Eble MD
635 Barnhill Dr, Indianapolis, IN 46202
Phone:
(317) 274-4806 (Phone)
Description:
There are 37 doctors at this site. Surgery is not performed at this site.
John Nelson Eble Ii
Professional information
Dr. John Eble, Indianapolis IN - MD (Doctor of Medicine)
Specialties:
Anatomic & Clinical Pathology
Address:
IU Health Pathology Laboratory
350 W 11Th St SUITE 4010, Indianapolis 46202
(317) 491-6000 (Phone)
350 W 11Th St SUITE 4010, Indianapolis 46202
(317) 491-6000 (Phone)
Certifications:
Anatomic & Clinical Pathology, 1981
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Indiana University School Of Medicine
Graduated: 1976
Indiana University Med Center
Graduated: 1980
Indiana University School Of Medicine
Graduated: 1976
Indiana University Med Center
Graduated: 1980
John Nelson Eble, Indianapolis IN
Specialties:
Pathology, Anatomic Pathology & Clinical Pathology, Clinical Pathology/Laboratory Medicine
Work:
Iu Health Pathology Laboratory
350 W 11Th St, Indianapolis, IN 46202 Department of Pathology & Laboratory Medicine
535 Barnhill Dr, Indianapolis, IN 46202
350 W 11Th St, Indianapolis, IN 46202 Department of Pathology & Laboratory Medicine
535 Barnhill Dr, Indianapolis, IN 46202
Education:
Indiana University(1977)
Professor At Indiana University
Position:
Professor at Indiana University
Location:
Indianapolis, Indiana Area
Industry:
Health, Wellness and Fitness
Work:
Indiana University
-
Professor
John N Eble, Indianapolis IN
Specialties:
Pathologist
Address:
635 Barnhill Dr, Indianapolis, IN 46202
Education:
Indiana University, School of Medicine - Doctor of Medicine
Board certifications:
American Board of Pathology Certification in Clinical Pathology (Pathology)
Methods And Compositions For The Use Of Apurinic/Apyrimidinic Endonucleases
US Patent:
6190661, Feb 20, 2001
Filed:
Jun 18, 1999
Appl. No.:
9/336890
Inventors:
Mark R. Kelley - Zionsville IN
John Duquid - Brownsburg IN
John Eble - Indianapolis IN
John Duquid - Brownsburg IN
John Eble - Indianapolis IN
Assignee:
Advanced Research & Technology Institute - Bloomington IN
International Classification:
A61K 39395, A61K 31711
US Classification:
4241391
Abstract:
Disclosed are methods and compositions for identifying, monitoring and treating premalignant and malignant conditions in a human subject. The present invention further discloses methods and compositions for determining cells undergoing apoptosis, and for increasing the efficacy of a cancer therapy. The methods involve the use of apurinic/apyrimidinic endonuclease (APE), independently, as a marker for (pre)malignant conditions and for apoptosis. Also described are polyclonal antibody preparations for use in methods for detecting APE and methods for modulating expression susceptibility of cells to apoptosis.
Methods And Compositions For The Use Of Apurinic/Apyrimidinic Endonucleases
US Patent:
5919643, Jul 6, 1999
Filed:
Jun 11, 1997
Appl. No.:
8/872719
Inventors:
Mark R. Kelley - Zionsville IN
John Duguid - Brownsburg IN
John Eble - Indianapolis IN
John Duguid - Brownsburg IN
John Eble - Indianapolis IN
Assignee:
Advanced Research & Technology Institute - Bloomington IN
International Classification:
C12Q 144, C12N 922
US Classification:
435 19
Abstract:
Disclosed are methods and compositions for identifying, monitoring and treating premalignant and malignant conditions in a human subject. The present invention further discloses methods and compositions for determining cells undergoing apoptosis, and for increasing the efficacy of a cancer therapy. The methods involve the use of apurinic/apyrimidinic endonuclease (APE), independently, as a marker for (pre)malignant conditions and for apoptosis. Also described are polyclonal antibody preparations for use in methods for detecting APE and methods for modulating expression susceptibility of cells to apoptosis.